Literature DB >> 6982729

An analysis of lymphocyte subpopulations in schizophrenic patients.

L E DeLisi, S Goodman, L M Neckers, R J Wyatt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6982729

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  11 in total

1.  Autoantibodies to brain and polynucleotides in patients with schizophrenia: a puzzle.

Authors:  H A Teplizki; B Sela; Y Shoenfeld
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

2.  T-lymphocyte subpopulations in schizophrenic patients.

Authors:  A Henneberg; B Riedl; H O Dumke; H H Kornhuber
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1990

Review 3.  Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission.

Authors:  N Muller; M Schwarz
Journal:  Neurotox Res       Date:  2006-10       Impact factor: 3.911

4.  Deficient natural killer cell (NK) activity and macrophage functioning in schizophrenic patients.

Authors:  L E DeLisi; J R Ortaldo; A E Maluish; R J Wyatt
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

Review 5.  Molecular genetics of schizophrenia: past, present and future.

Authors:  Suman Prasad; Prachi Semwal; Smita Deshpande; Triptish Bhatia; V L Nimgaonkar; B K Thelma
Journal:  J Biosci       Date:  2002-02       Impact factor: 1.826

Review 6.  Adaptive Immunity in Schizophrenia: Functional Implications of T Cells in the Etiology, Course and Treatment.

Authors:  Monojit Debnath
Journal:  J Neuroimmune Pharmacol       Date:  2015-07-11       Impact factor: 4.147

Review 7.  Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications.

Authors:  Barbara Sperner-Unterweger
Journal:  Drugs       Date:  2005       Impact factor: 9.546

8.  Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects.

Authors:  Brian J Miller; Bintou Gassama; Dale Sebastian; Peter Buckley; Andrew Mellor
Journal:  Biol Psychiatry       Date:  2012-10-11       Impact factor: 13.382

9.  Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression.

Authors:  M Maes; H Y Meltzer; P Buckley; E Bosmans
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

10.  Immune abnormalities in patients with autism.

Authors:  R P Warren; N C Margaretten; N C Pace; A Foster
Journal:  J Autism Dev Disord       Date:  1986-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.